Latest headlines
Gilead Sciences News
The latest Gilead Sciences (GILD) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these GILD headlines next to the live Gilead Sciences Fear and Greed Index.
Latest Gilead Sciences Headlines41
In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech?
fool.com · Aug 20, 2026
Robbins LLP Encourages ITOC Stockholders Who Lost Money Investing in iTonic Holdings Ltd. to Contact the Firm for Information About Leading the Class Action
newsfilecorp.com · Aug 19, 2026
Worried About a Market Crash? These 3 Stocks Beat the S&P 500 in 2008 and 2022
fool.com · Aug 19, 2026
Is Gilead's Expanding HIV Portfolio a Growth Catalyst?
zacks.com · Aug 18, 2026
Gilead Sciences Has Quietly Become One of the Most Underrated Turnaround Stories in Healthcare. Here's Why Wall Street Is Excited.
fool.com · Aug 18, 2026
Assembly Biosciences: Gilead Advancements For GS-1179 And ABI-6250 Is A Bullish Signal
seekingalpha.com · Aug 16, 2026
Court rules companies can't import Gilead medications from overseas in blow to AFP health programs
cnbc.com · Aug 14, 2026
Gilead Sciences: The Market May Be Underestimating Its Growth (Rating Upgrade)
seekingalpha.com · Aug 10, 2026
GILD Q2 Earnings Call Raises Outlook on HIV and PrEP Strength
zacks.com · Aug 7, 2026
Gilead Sciences: A Strong Quarter Hidden Behind Ugly Earnings
seekingalpha.com · Aug 6, 2026
GILD Q2 Earnings Beat on HIV and Trodelvy Growth, Product Sales Outlook Raised
zacks.com · Aug 5, 2026
Gilead Sciences Inc (GILD) (Q2 2026) Earnings Call Highlights: PrEP Sales Double to $1B, HIV Growth Accelerates, and Strategic Pipeline Advances
gurufocus.com · Aug 5, 2026
CORRECTING and REPLACING Gilead Sciences Announces Second Quarter 2026 Financial Results
gurufocus.com · Aug 4, 2026
CORRECTING and REPLACING Gilead Sciences Announces Second Quarter 2026 Financial Results
businesswire.com · Aug 4, 2026
Gilead Sciences, Inc. (GILD) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 4, 2026
Gilead Sciences Q2 Earnings Call Highlights
marketbeat.com · Aug 4, 2026
Compared to Estimates, Gilead (GILD) Q2 Earnings: A Look at Key Metrics
zacks.com · Aug 4, 2026
Gilead Sciences (GILD) Reports Q2 Loss, Beats Revenue Estimates
zacks.com · Aug 4, 2026
AHF Crowns Gilead Corporate Welfare King
businesswire.com · Aug 4, 2026
Is Gilead Sciences Inc (GILD) Worth the Current Valuation? Q2 Earnings Show $(8.45) EPS Miss and $7.8 Billion Revenue -- GF Score: 75/100, 40.5% Overvalued
gurufocus.com · Aug 4, 2026
Gilead Sciences Swings to Loss on R&D Costs as HIV-Drug Sales Lift Revenue
wsj.com · Aug 4, 2026
Gilead second-quarter sales rise 8%, beating Wall Street estimates
reuters.com · Aug 4, 2026
Gilead Sciences Announces Second Quarter 2026 Financial Results
businesswire.com · Aug 4, 2026
California's highest court rules for Gilead, says drugmakers don't have 'duty to innovate'
reuters.com · Aug 3, 2026
California's highest court rules for Gilead in 'duty to innovate' case
reuters.com · Aug 3, 2026
Seeking Clues to Gilead (GILD) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
zacks.com · Jul 30, 2026
Is Most-Watched Stock Gilead Sciences, Inc. (GILD) Worth Betting on Now?
zacks.com · Jul 30, 2026
Gilead: Buy The Distortion Before Q2 Clears It Up
seekingalpha.com · Jul 30, 2026
Gilead to Report Q2 Earnings: How Should You Play the Stock Now?
zacks.com · Jul 29, 2026
Gilead Sciences (GILD) Laps the Stock Market: Here's Why
zacks.com · Jul 28, 2026
Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for
zacks.com · Jul 28, 2026
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know
zacks.com · Jul 24, 2026
CHMP Recommends Gilead's Trodelvy® Plus Keytruda® in PD-(L)1-Positive First-Line Metastatic Triple-Negative Breast Cancer
businesswire.com · Jul 24, 2026
Can Gilead's Efforts to Develop New Treatments Solidify HIV Franchise?
zacks.com · Jul 23, 2026
Which iShares Healthcare ETF Is the Better Buy: Diversified IXJ or Biotech-Focused IBB?
fool.com · Jul 23, 2026
Gilead Sciences to Release Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
businesswire.com · Jul 21, 2026
Gilead, Merck weekly HIV pill keeps virus suppressed in late-stage trials
reuters.com · Jul 21, 2026
Investigational Once-Weekly Oral HIV Treatment Regimen of Islatravir and Lenacapavir Maintained Virological Suppression in Adults With HIV Who Switched Antiretroviral Therapy
businesswire.com · Jul 21, 2026
Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know
zacks.com · Jul 17, 2026
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
zacks.com · Jul 16, 2026
Congo begins trial of Gilead's experimental antiviral for Ebola Bundibugyo
reuters.com · Jul 14, 2026
Why Is Gilead Sciences Up or Down Today?
When Gilead Sciences (GILD) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a GILD move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why Gilead Sciences is up or down today.
How Gilead Sciences News Affects the Price
News does not move the Gilead Sciences (GILD) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the Gilead Sciences Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in Gilead Sciences trading volume. That is the chain to watch: headline, sentiment, volume, then the GILD price.
Trade the Gilead Sciences News With Sentiment
Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch Gilead Sciences trading volume spike on a big story, check the Gilead Sciences price history for context, follow the live GILD price, see the Gilead Sciences price prediction, and read the Gilead Sciences Fear and Greed Index for mood.
How do you feel about Gilead Sciences?
1DFrequently asked questions
Why is Gilead Sciences up or down today?
What is the latest Gilead Sciences news?
Where does Gilead Sciences news come from?
How often is Gilead Sciences news updated?
How does Gilead Sciences news relate to its Fear and Greed Index?
Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.